- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/72 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 211/72
Total number of patents in this class: 149
10-year publication summary
|
6
|
9
|
4
|
6
|
1
|
4
|
4
|
4
|
2
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corteva Agriscience LLC | 2686 |
8 |
| Shanghai Curegene Pharmaceutical Co., Ltd. | 14 |
6 |
| Bayer Cropscience AG | 2038 |
5 |
| The Regents of the University of Michigan | 4718 |
5 |
| Catabasis Pharmaceuticals, Inc. | 36 |
5 |
| PureTech Lyt-100, Inc. | 24 |
5 |
| Boehringer Ingelheim International GmbH | 4641 |
4 |
| Allergan, Inc. | 2340 |
4 |
| Coral Sunscreen Pty Ltd | 5 |
4 |
| Syntrix Biosystems, Inc. | 30 |
4 |
| Bristol-myers Squibb Company | 4881 |
3 |
| Akebia Therapeutics, Inc. | 114 |
3 |
| H. Lundbeck A/S | 1250 |
3 |
| Novartis AG | 10741 |
2 |
| LG Chem, Ltd. | 17641 |
2 |
| Pfizer Inc. | 3368 |
2 |
| Bayer Intellectual Property GmbH | 2498 |
2 |
| Amgen Inc. | 4081 |
2 |
| University of Florida Research Foundation, Inc. | 4037 |
2 |
| Ardea Biosciences, Inc. | 72 |
2 |
| Other owners | 76 |